In sharp contrast to the cohort of oligo-metastatic CRC, there was no positive correlation between FGFR3 overexpression and survival in primary CRC (p=0.985, HR=1.01 [0.49-2.05]; Figure 3). The gene discussed is FGFR3; the disease is colorectal carcinoma.